These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31329022)

  • 1.
    Gostev V; Sopova J; Kalinogorskaya O; Tsvetkova I; Lobzin Y; Klotchenko S; Sidorenko S
    Microb Drug Resist; 2019 Dec; 25(10):1401-1409. PubMed ID: 31329022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals.
    Andrey DO; François P; Manzano C; Bonetti EJ; Harbarth S; Schrenzel J; Kelley WL; Renzoni A
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):343-350. PubMed ID: 27744604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftaroline Resistance by Clone-Specific Polymorphism in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus.
    Lee H; Yoon EJ; Kim D; Kim JW; Lee KJ; Kim HS; Kim YR; Shin JH; Shin JH; Shin KS; Kim YA; Uh Y; Jeong SH
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftobiprole- and ceftaroline-resistant methicillin-resistant Staphylococcus aureus.
    Chan LC; Basuino L; Diep B; Hamilton S; Chatterjee SS; Chambers HF
    Antimicrob Agents Chemother; 2015 May; 59(5):2960-3. PubMed ID: 25753637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998.
    Kelley WL; Jousselin A; Barras C; Lelong E; Renzoni A
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1922-30. PubMed ID: 25583724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective.
    Alm RA; McLaughlin RE; Kos VN; Sader HS; Iaconis JP; Lahiri SD
    J Antimicrob Chemother; 2014 Aug; 69(8):2065-75. PubMed ID: 24777906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic analysis of Italian MRSA strains exhibiting low-level ceftaroline and ceftobiprole resistance.
    Bongiorno D; Mongelli G; Stefani S; Campanile F
    Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114852. PubMed ID: 31288948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.
    Mendes RE; Tsakris A; Sader HS; Jones RN; Biek D; McGhee P; Appelbaum PC; Kosowska-Shick K
    J Antimicrob Chemother; 2012 Jun; 67(6):1321-4. PubMed ID: 22398650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in
    Lai L-Y; Satishkumar N; Cardozo S; Hemmadi V; Marques LB; Huang L; Filipe SR; Pinho MG; Chambers HF; Chatterjee SS
    mBio; 2024 May; 15(5):e0288923. PubMed ID: 38530033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program.
    Biedenbach DJ; Alm RA; Lahiri SD; Reiszner E; Hoban DJ; Sahm DF; Bouchillon SK; Ambler JE
    Antimicrob Agents Chemother; 2016 Jan; 60(1):343-7. PubMed ID: 26503659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates.
    Sader HS; Rhomberg PR; Doyle TB; Flamm RK; Mendes RE
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance.
    Greninger AL; Chatterjee SS; Chan LC; Hamilton SM; Chambers HF; Chiu CY
    PLoS One; 2016; 11(2):e0149541. PubMed ID: 26890675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline.
    Lahiri SD; McLaughlin RE; Whiteaker JD; Ambler JE; Alm RA
    J Antimicrob Chemother; 2015 Sep; 70(9):2488-98. PubMed ID: 26045529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of non-PBP2a resistance mechanisms in Staphylococcus aureus after serial passage with ceftaroline: involvement of other PBPs.
    Lahiri SD; Alm RA
    J Antimicrob Chemother; 2016 Nov; 71(11):3050-3057. PubMed ID: 27494915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of ceftaroline against clinical Staphylococcus aureus isolates collected during a national survey conducted in Belgian hospitals.
    Argudín MA; Dodémont M; Taguemount M; Roisin S; de Mendonça R; Deplano A; Nonhoff C; Denis O
    J Antimicrob Chemother; 2017 Jan; 72(1):56-59. PubMed ID: 27634917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of Staphylococcus aureus isolates carrying different PBP2a alleles to develop resistance to ceftaroline.
    Lahiri SD; Alm RA
    J Antimicrob Chemother; 2016 Jan; 71(1):34-40. PubMed ID: 26483514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the
    Sommer A; Fuchs S; Layer F; Schaudinn C; Weber RE; Richard H; Erdmann MB; Laue M; Schuster CF; Werner G; Strommenger B
    Microb Genom; 2021 Sep; 7(9):. PubMed ID: 34486969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftaroline fosamil salvage therapy: an option for reduced-vancomycin-susceptible MRSA bacteraemia.
    Espedido BA; Jensen SO; van Hal SJ
    J Antimicrob Chemother; 2015 Mar; 70(3):797-801. PubMed ID: 25406295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBP2a substitutions linked to ceftaroline resistance in MRSA isolates from the UK.
    Harrison EM; Ba X; Blane B; Ellington MJ; Loeffler A; Hill RL; Holmes MA; Peacock SJ
    J Antimicrob Chemother; 2016 Jan; 71(1):268-9. PubMed ID: 26462986
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro susceptibility testing of ceftobiprole against 880 European respiratory tract infection isolates of methicillin-resistant Staphylococcus aureus followed by whole genome sequencing of ceftobiprole-resistant isolates.
    Hawser S; Kothari N; Karlowsky JA; Wiktorowicz T; Hamed K
    Diagn Microbiol Infect Dis; 2020 Apr; 96(4):114978. PubMed ID: 31952866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.